Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immuneering Corp | 344,000 | reported | 03 Feb 2026 | tx 18+1,361,496−5,040 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | GRANT_AWARD | Immuneering Corp | 344,000 | 0.00 USD | deriv |
| 15 Jan 2026 | PURCHASE | Immuneering Corp | 2,298 | 4.57 USD | |
| 15 Sept 2025 | GRANT_AWARD | Immuneering Corp | 14,880 | 1.43 USD | |
| 20 Jun 2025 | PURCHASE | Immuneering Corp | 7,415 | 2.70 USD | first after silence |
| 23 Jun 2025 | PURCHASE | Immuneering Corp | 6,007 | 2.43 USD | |
| 05 Feb 2025 | GRANT_AWARD | Immuneering Corp | 240,000 | 0.00 USD | deriv |
| 15 Mar 2024 | GRANT_AWARD | Immuneering Corp | 6,211 | 1.62 USD | |
| 20 Mar 2024 | PURCHASE | Immuneering Corp | 7,000 | 2.86 USD | first after silence |
| 08 Feb 2024 | GRANT_AWARD | Immuneering Corp | 130,900 | 0.00 USD | deriv |
| 15 Feb 2023 | GRANT_AWARD | Immuneering Corp | 187,000 | 0.00 USD | deriv |
| 25 May 2022 | PURCHASE | Immuneering Corp | 2,551 | 3.92 USD | |
| 23 Mar 2022 | PURCHASE | Immuneering Corp | 1,050 | 7.91 USD | |
| 10 Feb 2022 | GRANT_AWARD | Immuneering Corp | 83,100 | 0.00 USD | deriv |
| 22 Dec 2021 | GRANT_AWARD | Immuneering Corp | 322,691 | — | |
| 03 Aug 2021 | PURCHASE | Immuneering Corp | 1,353 | 15.00 USD | |
| 03 Aug 2021 | CONVERSION | Immuneering Corp | 5,040 | — | |
| 03 Aug 2021 | CONVERSION | Immuneering Corp | 1,636 | — | deriv |
| 03 Aug 2021 | CONVERSION | Immuneering Corp | 3,404 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 20 Jun 2025.